Response to Treatment for Chronic-active T Cell–mediated Rejection in Kidney Transplantation: A Report of 3 Cases

Response to Treatment for Chronic-active T Cell–mediated Rejection in Kidney Transplantation: A Report of 3 Cases

Bibliographic Details
Main Authors:	Hiroshi Noguchi, MD, PhD, Kaneyasu Nakagawa, MD, Kenji Ueki, MD, Akihiro Tsuchimoto, MD, PhD, Keizo Kaku, MD, PhD, Yasuhiro Okabe, MD, PhD, Masafumi Nakamura, MD, PhD
Format:	Article
Language:	English
Published:	Wolters Kluwer 2020-12-01
Series:	Transplantation Direct
Online Access:	http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001079

Similar Items

Impact of the Mayo Adhesive Probability Score on Donor and Recipient Outcomes After Living-donor Kidney Transplantation: A Retrospective, Single-center Study of 782 Transplants
by: Yu Sato, MD, et al.
Published: (2021-08-01)

Safety and Efficacy of Sodium-glucose Cotransporter 2 Inhibitors in Kidney Transplant Recipients With Pretransplant Type 2 Diabetes Mellitus: A Retrospective, Single-center, Inverse Probability of Treatment Weighting Analysis of 85 Transplant Patients
by: Yu Hisadome, MD, et al.
Published: (2021-11-01)

Acute Antibody-mediated Rejection Coexisting With T Cell–mediated Rejection in Pediatric ABO-incompatible Transplantation
by: Yusuke Yanagi, MD, PhD, et al.
Published: (2022-09-01)

Acute Rejection After Kidney Transplantation Associates With Circulating MicroRNAs and Vascular Injury
by: Roel Bijkerk, PhD, et al.
Published: (2017-07-01)

Alloreactive T cells to Assess Acute Rejection Risk in Kidney Transplant Recipients
by: Aleixandra Mendoza Rojas, MSc, et al.
Published: (2023-05-01)

The MEK Inhibitor Trametinib Suppresses Major Histocompatibility Antigen-mismatched Rejection Following Pancreatic Islet Transplantation
by: Seiichiro Tada, MD, et al.
Published: (2020-09-01)

Protection From Second Warm Ischemic Injury Using a Thermal Barrier Bag in Kidney Transplantation
by: Kentaro Ide, MD, PhD, et al.
Published: (2023-03-01)

Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase?
by: Tetsuya Tajima, MD, et al.
Published: (2019-10-01)

The Role of Dynamic DNA Methylation in Liver Transplant Rejection in Children
by: Mylarappa Ningappa, PhD, et al.
Published: (2022-11-01)

Mast Cells in Kidney Transplant Biopsies With Borderline T Cell-mediated Rejection and Their Relation to Chronicity
by: Hilal Varol, MD, et al.
Published: (2023-05-01)

The Optimization of Short-Term Hepatocyte Preservation Before Transplantation
by: Kengo Fukuoka, MD, et al.
Published: (2017-07-01)

Time-dependent blood eosinophilia count increases the risk of kidney allograft rejection
by: Luc Colas, MD, PhD, et al.
Published: (2021-11-01)

Recurrent Mild Acute Rejections and Donor-specific Antibodies as Risk Factors for Cardiac Allograft Vasculopathy in a National Pediatric Heart Transplant Cohort
by: Anu K. Kaskinen, MD, PhD, et al.
Published: (2023-10-01)

Reliability and Validity of the Japanese Version of the Basel Assessment of Adherence to Immunosuppressive Medications Scale in Kidney Transplant Recipients
by: Akihiro Kosoku, MD, PhD, et al.
Published: (2023-03-01)

Cellular Mechanisms of Rejection of Optic and Sciatic Nerve Transplants: An Observational Study
by: Merve Yonar, MD, et al.
Published: (2020-08-01)

Extracorporeal Photopheresis Reduces Fibrotic and Inflammatory Transcriptomic Biological Marker of Chronic Antibody-mediated Kidney Rejection
by: Arnaud Lionet, MD, et al.
Published: (2024-03-01)

A Novel Method for Urinary Tract Reconstruction in Transplanted Embryonic Kidneys Using the Hybrid Stent: A Pig Study
by: Kenji Matsui, MD, et al.
Published: (2022-03-01)

A Combined microRNA and Chemokine Profile in Urine to Identify Rejection After Kidney Transplantation
by: Els M. Gielis, MD, PhD, et al.
Published: (2021-07-01)

Blood Pressure Treatment in Kidney Transplant Recipients—Can We Improve?
by: Mari O. Onsøien, et al.
Published: (2021-04-01)

Cancer After Pediatric Kidney Transplantation: A Long-term Single-center Experience in Japan
by: Tomoo Yabuuchi, MD, et al.
Published: (2021-04-01)

Tuberculosis in Kidney Transplant Recipients: A Nationwide Cohort in a Low Tuberculosis Incidence Country
by: Thijs Feuth, MD, PhD, et al.
Published: (2023-09-01)

Heparin Conjugate Pretreatment of Kidneys From Deceased Donors Before Transplantation: Results From the First-in-human Randomized Phase I Trial
by: Amir Sedigh, MD, PhD, et al.
Published: (2023-01-01)

Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation
by: Yohei Yamada, MD, PhD, et al.
Published: (2018-02-01)

Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Kidney Transplant Rejection: Effect on Donor-derived Cell-free DNA and C-X-C Motif Chemokine Ligand 10
by: Katharina A. Mayer, MD, et al.
Published: (2022-12-01)

Impact of Postoperative Continuous Renal Replacement Therapy in Lung Transplant Recipients
by: Masato Katahira, MD, et al.
Published: (2020-06-01)

Predictors of Nonseroconversion to SARS-CoV-2 Vaccination in Kidney Transplant Recipients
by: Sophie C. Frölke, BSc, et al.
Published: (2022-11-01)

Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience
by: Yoshihide Ueda, MD, PhD, et al.
Published: (2017-12-01)

Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey
by: Nobuhisa Akamatsu, MD, PhD, et al.
Published: (2021-08-01)

Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection
by: Sergi Clotet-Freixas, PhD, et al.
Published: (2021-10-01)

Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis
by: Soulef Guendouz, MD, et al.
Published: (2022-07-01)

Urinary Endotrophin and Long-term Outcomes in Kidney Transplant Recipients
by: Firas F. Alkaff, MD, et al.
Published: (2024-03-01)

Urgent endovascular maneuvers to rescue a failing transplant kidney with a T-stent approach
by: Astrid Sofia Cavenaghi, MD, et al.
Published: (2023-06-01)

Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus
by: Yuichiro Okumura, MD, et al.
Published: (2017-09-01)

Sodium Hydrosulfide Treatment During Porcine Kidney Ex Vivo Perfusion and Transplantation
by: Thomas Agius, MS, et al.
Published: (2023-11-01)

Benefits of Kidney Transplantation or Living Donation?
by: François Gaillard, MD, PhD
Published: (2020-07-01)

Unilateral Chronic Lung Allograft Dysfunction Assessed by Biphasic Computed Tomographic Volumetry in Bilateral Living-donor Lobar Lung Transplantation
by: Masao Saito, MD, et al.
Published: (2018-11-01)

Prediction of Early BK Virus Infection in Kidney Transplant Recipients by the Number of Cells With Intranuclear Inclusion Bodies (Decoy Cells)
by: Yoshiteru Yamada, PhD, et al.
Published: (2018-02-01)

Reproducibility of Rejection Grading in Uterus Transplantation: A Multicenter Study
by: Verena Broecker, MD, et al.
Published: (2023-10-01)

HLA Homozygosity and Likelihood of Sensitization in Kidney Transplant Candidates
by: Joshua A. Rushakoff, MD, MPP, et al.
Published: (2022-05-01)

Successful Desensitization of T cell Flow Cytometry Crossmatch Positive Renal Transplant Recipients Using Plasmapheresis and Super High-Dose Intravenous Immunoglobulin
by: Yoichi Kakuta, MD, PhD, et al.
Published: (2018-01-01)